Role of complement and potential of complement inhibitors in myasthenia gravis and neuromyelitis optica spectrum disorders: a brief review
出版年份 2019 全文链接
标题
Role of complement and potential of complement inhibitors in myasthenia gravis and neuromyelitis optica spectrum disorders: a brief review
作者
关键词
-
出版物
JOURNAL OF NEUROLOGY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-09-03
DOI
10.1007/s00415-019-09498-4
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- CD55 upregulation in astrocytes by statins as potential therapy for AQP4-IgG seropositive neuromyelitis optica
- (2019) Lukmanee Tradtrantip et al. Journal of Neuroinflammation
- Ravulizumab: First Global Approval
- (2019) Kate McKeage DRUGS
- Effectiveness of rituximab in neuromyelitis optica: a meta-analysis
- (2019) Fulin Gao et al. BMC Neurology
- Eculizumab in Aquaporin-4–Positive Neuromyelitis Optica Spectrum Disorder
- (2019) Sean J. Pittock et al. NEW ENGLAND JOURNAL OF MEDICINE
- Serological and experimental studies in different forms of myasthenia gravis
- (2018) Angela Vincent et al. Annals of the New York Academy of Sciences
- Design and preclinical characterization of ALXN1210: A novel anti-C5 antibody with extended duration of action
- (2018) Douglas Sheridan et al. PLoS One
- Emerging Therapies in Hereditary Angioedema
- (2017) Meng Chen et al. IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA
- What’s new in neuromyelitis optica? A short review for the clinical neurologist
- (2017) Daniel Whittam et al. JOURNAL OF NEUROLOGY
- What proportion of AQP4-IgG-negative NMO spectrum disorder patients are MOG-IgG positive? A cross sectional study of 132 patients
- (2017) Shahd H. M. Hamid et al. JOURNAL OF NEUROLOGY
- Short delay to initiate plasma exchange is the strongest predictor of outcome in severe attacks of NMO spectrum disorders
- (2017) Mickael Bonnan et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
- (2017) James F Howard et al. LANCET NEUROLOGY
- Rituximab treatment of myasthenia gravis: A systematic review
- (2017) Rup Tandan et al. MUSCLE & NERVE
- Letter re: A randomized controlled trial of methotrexate for patients with generalized myasthenia gravis
- (2017) Jeannine M. Heckmann et al. NEUROLOGY
- Structure and activation of C1, the complex initiating the classical pathway of the complement cascade
- (2017) Simon A. Mortensen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Autoantibody-induced internalization of CNS AQP4 water channel and EAAT2 glutamate transporter requires astrocytic Fc receptor
- (2017) Shannon R. Hinson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Therapeutic options in neuromyelitis optica spectrum disorders
- (2016) Joanna Kitley et al. Expert Review of Neurotherapeutics
- Complement Destabilizes Cardiomyocyte Function In Vivo after Polymicrobial Sepsis and In Vitro
- (2016) Miriam Kalbitz et al. JOURNAL OF IMMUNOLOGY
- Plasma complement biomarkers distinguish multiple sclerosis and neuromyelitis optica spectrum disorder
- (2016) Svetlana Hakobyan et al. Multiple Sclerosis Journal
- Effectiveness of mycophenolate mofetil as first-line therapy in AQP4-IgG, MOG-IgG, and seronegative neuromyelitis optica spectrum disorders
- (2016) Alexis Montcuquet et al. Multiple Sclerosis Journal
- A randomized controlled trial of methotrexate for patients with generalized myasthenia gravis
- (2016) Mamatha Pasnoor et al. NEUROLOGY
- Randomized Trial of Thymectomy in Myasthenia Gravis
- (2016) NEW ENGLAND JOURNAL OF MEDICINE
- Myasthenia Gravis
- (2016) Nils E. Gilhus NEW ENGLAND JOURNAL OF MEDICINE
- Therapeutic options in neuromyelitis optica spectrum disorders
- (2016) Joanna Kitley et al. Expert Review of Neurotherapeutics
- Clinical Characteristics of Patients With Double-Seronegative Myasthenia Gravis and Antibodies to Cortactin
- (2016) Elena Cortés-Vicente et al. JAMA Neurology
- Plasma complement biomarkers distinguish multiple sclerosis and neuromyelitis optica spectrum disorder
- (2016) Svetlana Hakobyan et al. Multiple Sclerosis Journal
- Effectiveness of mycophenolate mofetil as first-line therapy in AQP4-IgG, MOG-IgG, and seronegative neuromyelitis optica spectrum disorders
- (2016) Alexis Montcuquet et al. Multiple Sclerosis Journal
- Effects of ComplementC4Gene Copy Number Variations, Size Dichotomy, andC4ADeficiency on Genetic Risk and Clinical Presentation of Systemic Lupus Erythematosus in East Asian Populations
- (2016) Ji Yih Chen et al. Arthritis & Rheumatology
- Phase II study results of a replacement therapy for hereditary angioedema with subcutaneous C1-inhibitor concentrate
- (2015) B. L. Zuraw et al. ALLERGY
- Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses
- (2015) Ingo Kleiter et al. ANNALS OF NEUROLOGY
- Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies: a decade later
- (2015) Sean J. Pittock et al. Annals of the New York Academy of Sciences
- Guidelines for pre-clinical assessment of the acetylcholine receptor-specific passive transfer myasthenia gravis model—Recommendations for methods and experimental designs
- (2015) Linda L. Kusner et al. EXPERIMENTAL NEUROLOGY
- Intravenous immunoglobulin may reduce relapse frequency in neuromyelitis optica
- (2015) Shanthi Viswanathan et al. JOURNAL OF NEUROIMMUNOLOGY
- Epidemiological, clinical, and immunological characteristics of neuromyelitis optica: A review
- (2015) Wildéa Lice de Carvalho Jennings Pereira et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Role of membrane complement regulators in neuromyelitis optica
- (2015) Samira Saadoun et al. Multiple Sclerosis Journal
- Complement, a target for therapy in inflammatory and degenerative diseases
- (2015) B. Paul Morgan et al. NATURE REVIEWS DRUG DISCOVERY
- International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
- (2015) Dean M. Wingerchuk et al. NEUROLOGY
- Role of membrane complement regulators in neuromyelitis optica
- (2015) Samira Saadoun et al. Multiple Sclerosis Journal
- Cortactin autoantibodies in myasthenia gravis
- (2014) Eduard Gallardo et al. AUTOIMMUNITY REVIEWS
- Paroxysmal nocturnal hemoglobinuria
- (2014) R. A. Brodsky BLOOD
- Complement activation in patients with neuromyelitis optica
- (2014) Petra Nytrova et al. JOURNAL OF NEUROIMMUNOLOGY
- Syndrome of inappropriate antidiuretic hormone secretion in patients with aquaporin-4 antibody
- (2014) Shuxiang Pu et al. JOURNAL OF NEUROLOGY
- Are complement deficiencies really rare? Overview on prevalence, clinical importance and modern diagnostic approach
- (2014) Anete Sevciovic Grumach et al. MOLECULAR IMMUNOLOGY
- Compound heterozygous mutations in the C6 gene of a child with recurrent infections
- (2014) Dineke Westra et al. MOLECULAR IMMUNOLOGY
- Long-term efficacy, tolerability and retention rate of azathioprine in 103 aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder patients: a multicentre retrospective observational study from the UK
- (2014) Liene Elsone et al. Multiple Sclerosis Journal
- Autoantibodies to Agrin in Myasthenia Gravis Patients
- (2014) Bin Zhang et al. PLoS One
- C3 opsonization regulates endocytic handling of apoptotic cells resulting in enhanced T-cell responses to cargo-derived antigens
- (2014) L. Baudino et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Comparison of Relapse and Treatment Failure Rates Among Patients With Neuromyelitis Optica
- (2014) Maureen A. Mealy et al. JAMA Neurology
- Complement activation in multiple sclerosis plaques: an immunohistochemical analysis
- (2014) Gillian Ingram et al. Acta Neuropathologica Communications
- Neuromyelitis optica MOG-IgG causes reversible lesions in mouse brain
- (2014) Samira Saadoun et al. Acta Neuropathologica Communications
- The Pathology of an Autoimmune Astrocytopathy: Lessons Learned from Neuromyelitis Optica
- (2013) Claudia F. Lucchinetti et al. BRAIN PATHOLOGY
- Aquaporin-4 Antibodies (NMO-IgG) as a Serological Marker of Neuromyelitis Optica: A Critical Review of the Literature
- (2013) Sven Jarius et al. BRAIN PATHOLOGY
- Complement C2 siRNA mediated therapy of myasthenia gravis in mice
- (2013) Ruksana Huda et al. JOURNAL OF AUTOIMMUNITY
- A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis
- (2013) P. Zisimopoulou et al. JOURNAL OF AUTOIMMUNITY
- Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study
- (2013) Sean J Pittock et al. LANCET NEUROLOGY
- Role of intravenous immunoglobulin in the treatment of acute relapses of neuromyelitis optica: experience in 10 patients
- (2013) Liene Elsone et al. Multiple Sclerosis Journal
- A randomized, double-blind, placebo-controlled phase II study of eculizumab in patients with refractory generalized myasthenia gravis
- (2013) James F. Howard et al. MUSCLE & NERVE
- Targeting therapy to the neuromuscular junction: Proof of concept
- (2013) Linda L. Kusner et al. MUSCLE & NERVE
- MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4
- (2013) M. G. Huijbers et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice
- (2012) Rinse Klooster et al. BRAIN
- Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan
- (2012) Joanna Kitley et al. BRAIN
- Complement-dependent Cytotoxicity in Neuromyelitis Optica Requires Aquaporin-4 Protein Assembly in Orthogonal Arrays
- (2012) Puay-Wah Phuan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Comment on Neuromyelitis Optica: Potential Roles for Intravenous Immunoglobulin
- (2012) Denis Bernardi Bichuetti et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Axonal and oligodendrocyte-localized IgM and IgG deposits in MS lesions
- (2012) María C. Sádaba et al. JOURNAL OF NEUROIMMUNOLOGY
- Increase of complement fragment C5a in cerebrospinal fluid during exacerbation of neuromyelitis optica
- (2012) Hiroshi Kuroda et al. JOURNAL OF NEUROIMMUNOLOGY
- Acetylcholine Receptors Enable the Transport of Rapsyn from the Golgi Complex to the Plasma Membrane
- (2012) J.-Y. Park et al. JOURNAL OF NEUROSCIENCE
- Cell surface complement regulators moderate experimental myasthenia gravis pathology
- (2012) Linda L. Kusner et al. MUSCLE & NERVE
- Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies
- (2012) Julien Zuber et al. Nature Reviews Nephrology
- Estudio del efecto del tratamiento con inmunoglobulinas por vía intravenosa en la neuromielitis óptica
- (2012) M.J. Magraner et al. NEUROLOGIA
- Terminal Complement Inhibition Decreases Antibody-Mediated Rejection in Sensitized Renal Transplant Recipients
- (2011) M. D. Stegall et al. AMERICAN JOURNAL OF TRANSPLANTATION
- A single-blinded trial of methotrexate versus azathioprine as steroid-sparing agents in generalized myasthenia gravis
- (2011) Jeannine M Heckmann et al. BMC Neurology
- Complete deficiency of the sixth complement component (C6Q0), susceptibility to Neisseria meningitidis infections and analysis of the frequencies of C6Q0 gene defects in South Africans
- (2011) A. Orren et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Evidence against Cellular Internalizationin Vivoof NMO-IgG, Aquaporin-4, and Excitatory Amino Acid Transporter 2 in Neuromyelitis Optica
- (2011) Julien Ratelade et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Anti-CD20 B-cell depletion enhances monocyte reactivity in neuroimmunological disorders
- (2011) Klaus Lehmann-Horn et al. Journal of Neuroinflammation
- Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders
- (2011) Simone Mader et al. Journal of Neuroinflammation
- Molecular outcomes of neuromyelitis optica (NMO)-IgG binding to aquaporin-4 in astrocytes
- (2011) S. R. Hinson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Intractable vomiting as the initial presentation of neuromyelitis optica
- (2010) Metha Apiwattanakul et al. ANNALS OF NEUROLOGY
- Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice
- (2010) Samira Saadoun et al. BRAIN
- Expression Profile of Aquaporins in Human Nasolacrimal Duct Epithelium
- (2010) Kristin Jäger et al. CURRENT EYE RESEARCH
- Neuromyelitis optica: Pathogenicity of patient immunoglobulin in vivo
- (2009) Monika Bradl et al. ANNALS OF NEUROLOGY
- Novel complement inhibitor limits severity of experimentally myasthenia gravis
- (2009) Jindrich Soltys et al. ANNALS OF NEUROLOGY
- Prediction of Neuromyelitis Optica Attack Severity by Quantitation of Complement-Mediated Injury to Aquaporin-4–Expressing Cells
- (2009) Shannon R. Hinson et al. ARCHIVES OF NEUROLOGY
- Complement and its role in innate and adaptive immune responses
- (2009) Jason R Dunkelberger et al. CELL RESEARCH
- Narcolepsy as an initial manifestation of neuromyelitis optica with antiaquaporin-4 antibody
- (2009) T. Baba et al. JOURNAL OF NEUROLOGY
- Neurological autoimmunity targeting aquaporin-4
- (2009) S.R. Hinson et al. NEUROSCIENCE
- Treatment of Myasthenia Gravis by Preventing Acetylcholine Receptor Modulation
- (2008) Mario Losen et al. Annals of the New York Academy of Sciences
- Aquaporin-4 Antibodies in Neuromyelitis Optica and Longitudinally Extensive Transverse Myelitis
- (2008) Patrick Waters et al. ARCHIVES OF NEUROLOGY
- Aquaporin-4–binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2
- (2008) Shannon R. Hinson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Hypercomplementemia at relapse in patients with anti-aquaporin-4 antibody
- (2008) H Doi et al. Multiple Sclerosis Journal
- An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis
- (2008) D. B. Sanders et al. NEUROLOGY
- Prevention of experimental autoimmune myasthenia gravis by rat Crry-Ig: A model agent for long-term complement inhibition in vivo
- (2007) Natalie J. Hepburn et al. MOLECULAR IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started